BMC Cancer

official impact factor 3.15

Open Access

CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum

Anna Isinger*, Misha Bhat, Ake Borg and Mef Nilbert

BMC Cancer 2006, 6:64 doi:10.1186/1471-2407-6-64

Accesses  

  • Last 30 days: 15 accesses
  • Last year: 218 accesses
  • All time: 1371 accesses

Cited by

BioMed Central: 1 citation

Research article   Open Access

CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer

Sara Margolin, Hans Eiberg, Annika Lindblom, Marie Bisgaard BMC Cancer 2007, 7:163 (17 August 2007)